NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION Trademark
Trademark Overview
On Wednesday, September 27, 2023, a trademark application was filed for NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION with the United States Patent and Trademark Office. The USPTO has given the NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION trademark a serial number of 98199468. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, August 22, 2024. This trademark is owned by National Community Oncology Dispensing Association, Inc.. The NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Testing, analysis and evaluation of service providers to determine conformity with established accreditation standards; Testing, analysis and evaluation of dispensing pharmacy within an oncology center of excellence to determine conformity with established accreditation standards
General Information
| Serial Number | 98199468 |
| Word Mark | NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION |
| Filing Date | Wednesday, September 27, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Thursday, August 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of a graphic design around the words "NCODA." For the stylized image the mark consists of the letters "NCODA" with the letters in uppercase and no space in between the letters, with the letters appearing in blue bold font, and the letter "A" appearing with a gold star appearing in the center of the letter with the gold color appearing darker at the points of the star and fading to a lighter gold at the center. The mark also includes the words (appearing centered directly under the word "NCODA": "CENTER OF EXCELLENCE") in uppercase bold orange font, and the words "MEDICALLY INTEGRATED PHARMACY ACCREDITATION" appearing in smaller uppercase blue bold font. The words described appear in the center of the mark with an orange circle appearing at the top and bottom of the words, and a parallel blue circle appearing directly on the right half of the circle located on the top right half of the circle, and the bottom right half of the circle. |
| Indication of Colors claimed | The color(s) blue, orange, and gold is/are claimed as a feature of the mark. |
| NOT AVAILABLE | Center of Excellence Medically Integrated Pharmacy Accreditation |
| Goods and Services | Testing, analysis and evaluation of service providers to determine conformity with established accreditation standards; Testing, analysis and evaluation of dispensing pharmacy within an oncology center of excellence to determine conformity with established accreditation standards |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 27, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, February 9, 2022 |
| First Use In Commerce Date | Wednesday, February 9, 2022 |
Trademark Owner History
| Party Name | National Community Oncology Dispensing Association, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cazenovia, NY 13035 |
Trademark Events
| Event Date | Event Description |
| Wednesday, September 27, 2023 | NEW APPLICATION ENTERED |
| Friday, January 19, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, January 19, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 23, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, May 23, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 15, 2024 | ASSIGNED TO EXAMINER |
| Thursday, May 23, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, August 22, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 22, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 22, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
